CERo Therapeutics Inc. (CERO)
NASDAQ: CERO
· Real-Time Price · USD
8.43
-0.21 (-2.43%)
At close: Aug 20, 2025, 3:13 PM
8.43
0.00%
After-hours: Aug 20, 2025, 04:10 PM EDT
-2.43% (1D)
| Bid | 8.36 |
| Market Cap | 10.07M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.9M |
| EPS (ttm) | -577.61 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.14 |
| Analyst | Buy |
| Ask | 8.8 |
| Volume | 11,416 |
| Avg. Volume (20D) | 1,125,323 |
| Open | 8.61 |
| Previous Close | 8.64 |
| Day's Range | 8.26 - 8.73 |
| 52-Week Range | 6.71 - 896.00 |
| Beta | 0.49 |
About CERO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CERO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CERO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+188.65%
CERo Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
3 months ago
+38.84%
CERo Therapeutics Holdings shares are trading higher after the company announced the key clinical trial site location for its Phase 1 CER-1236 trial.
